Showing results (1-10 of 101) with videos related to
Sort By:
Pageof 11
Cancer Journal (Sudbury, Mass.)|August 8, 2014
Inducible expression of B7-H1 (PD-L1) and its selective role in tumor site immune modulationMiguel F Sanmamed, Lieping ChenCell|October 6, 2018
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to NormalizationMiguel F Sanmamed, Lieping ChenClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2020
Senescent T Cells as a Resistance Mechanism to Lung Cancer ImmunotherapyDiego Salas-Benito, Iñaki Eguren-Santamaria, Miguel F SanmamedClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020
Siglec-15 as an Emerging Target for Next-generation Cancer ImmunotherapyJingwei Sun, Qiao Lu, Miguel F Sanmamed, et al.Cancer Discovery|November 1, 2024
Immunogenicity and Efficacy of Personalized Adjuvant mRNA Cancer VaccinesPedro Berraondo, Raquel Cuesta, Miguel F Sanmamed, et al.Science Translational Medicine|June 14, 2019
Twists and turns to translating 4-1BB cancer immunotherapyMiguel F Sanmamed, Iñaki Etxeberría, Itziar Otano, et al.Cancer Journal (Sudbury, Mass.)|December 10, 2020
Overview of Lung Cancer ImmunotherapyMiguel F Sanmamed, Iñaki Eguren-Santamaria, Kurt A SchalperBlood|November 10, 2017
Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategiesCariad Chester, Miguel F Sanmamed, Jun Wang, et al.Nature Cancer|June 28, 2022
Charting roadmaps towards novel and safe synergistic immunotherapy combinationsMiguel F Sanmamed, Pedro Berraondo, Maria E Rodriguez-Ruiz, et al.Methods in Cell Biology|January 29, 2023
Mass cytometry to characterize the immune lung cancer microenvironmentTi Badri, Iñaki Eguren-Santamaria, Eva Fernandez-Pierola, et al.Pageof 11